Rs 1,680 Puts — Just Below Current Price — Draw 4,967 Contracts on Sun Pharmaceutical Industries Ltd

Put Options Event and Cash Market Context

On 16 Apr 2026, Sun Pharmaceutical Industries Ltd witnessed 4,967 put contracts traded at the Rs 1,680 strike, with a turnover of approximately ₹485.9 lakhs. The open interest at this strike stands at 1,625 contracts, indicating that a significant portion of the traded volume represents fresh positioning rather than merely adjustments to existing positions.

The underlying stock price closed at Rs 1,689.80, down 1.02% on the day and underperforming its sector by 0.36%. Notably, the stock is trading below all major moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling a sustained downtrend. Delivery volumes have also declined by 2.38% compared to the 5-day average, suggesting weakening investor participation in the cash market.

This combination of falling price and subdued delivery volume sets a complex backdrop for interpreting the put activity — does the options market anticipate further downside, or is this a strategic hedge?

Strike Price Analysis: Moneyness and Intent

The Rs 1,680 put strike is approximately 0.56% out-of-the-money (OTM) relative to the current price of Rs 1,689.80. This near-the-money positioning is critical in decoding the intent behind the put contracts. Puts that are close to or at-the-money (ATM) often indicate directional bearish bets, as buyers seek protection against imminent declines. Conversely, deep OTM puts typically serve as hedges against more severe drops or as part of complex option strategies.

Given the stock's recent weakness and the strike's proximity, the put activity likely reflects a combination of fresh bearish positioning and protective hedging. The relatively high turnover and open interest suggest that traders are actively positioning for potential downside risks in the near term, especially with the 28 Apr 2026 expiry less than two weeks away.

Interpreting the Put Activity: Bearish, Hedging, or Put Writing?

Put options inherently carry ambiguous signals. The three primary interpretations for heavy put activity are: outright bearish bets (put buying), hedging of existing long positions, or put writing (selling puts as a bullish strategy). In this case, the stock's downtrend and the strike's ATM status lean towards bearish positioning or protective hedging rather than put writing.

Put writing typically involves collecting premium on OTM strikes when the seller expects the stock to remain above the strike price. Here, the strike is very close to the current price, and the stock is trading below all key moving averages, which reduces the likelihood of put writing as the dominant strategy. Instead, the data points to traders either buying puts to protect existing long holdings or speculating on further declines.

However, the open interest of 1,625 contracts compared to the 4,967 contracts traded indicates that a substantial portion of activity is fresh, not just rollovers or closing trades. This fresh activity could be a mix of new bearish bets and hedging, reflecting uncertainty in the near-term outlook for Sun Pharmaceutical Industries Ltd.

Open Interest and Contracts Analysis

The ratio of contracts traded to open interest at the Rs 1,680 strike is roughly 3:1, indicating significant fresh activity on 16 Apr 2026. This suggests that traders are not merely adjusting existing positions but are actively establishing new ones. The open interest level, while moderate, supports the view that this strike is a focal point for near-term positioning ahead of expiry.

Such fresh put buying activity near the money, combined with the stock's recent underperformance, often signals increased caution or outright bearish sentiment. Yet, given the stock's liquidity and large market capitalisation of over ₹4,03,460 crores, some of this activity could also be institutional hedging to protect profits or limit downside risk in a volatile environment.

Cash Market Context: Technicals and Delivery Volumes

Sun Pharmaceutical Industries Ltd is trading below all major moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — a technical configuration that typically signals bearish momentum. The stock's 1-day return of -0.97% contrasts with the Sensex's modest gain of 0.13%, underscoring relative weakness.

Delivery volumes have declined by 2.38% compared to the 5-day average, with 26.29 lakh shares delivered on 15 Apr 2026. This drop in investor participation may be contributing to the cautious stance in the options market, as put buyers seek protection amid thinning conviction in the cash market rally.

The Rs 1,680 strike roughly aligns with a support zone just below the current price, which could be a natural level for hedging activity. Traders might be buying puts here to guard against a pullback to this technical support, rather than anticipating a sharp collapse — is this a prudent hedge or a sign of deeper concerns?

Fundamental and Sector Context

Sun Pharmaceutical Industries Ltd operates in the Pharmaceuticals & Biotechnology sector, a space that often experiences volatility due to regulatory developments and patent expiries. The company’s large-cap status and market capitalisation of ₹4,03,460 crores provide it with resilience, but sector headwinds can weigh on near-term price action.

While fundamentals remain important, the current options activity appears more influenced by technical and market sentiment factors than by any immediate fundamental shock.

Conclusion: Protective Hedging or Bearish Positioning?

The heavy put activity at the Rs 1,680 strike, just below the current price of Rs 1,689.80, combined with the stock’s downtrend and declining delivery volumes, points to a cautious stance among traders. The data suggests a blend of protective hedging by existing long holders and fresh bearish bets anticipating further weakness ahead of the 28 Apr 2026 expiry.

Put writing as a bullish strategy appears less likely given the strike’s proximity and the stock’s technical weakness. Instead, the options market seems to be positioning for potential downside risk, while also managing exposure amid uncertain momentum.

With the stock trading below all key moving averages and delivery volumes falling, should investors consider this put activity a warning signal or a prudent hedge?

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →

Options trading involves risk and is not suitable for all investors. Please consider your risk tolerance and seek professional advice before engaging in options strategies.